Bharat Immunologicals Price to Earning

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 22.20  0.95  4.47%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Price to Earning Analysis

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Bharat Immunologicals 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
 = 
(17.70) times

About Price to Earning

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition
Based on latest financial disclosure the price to earning indicator of Bharat Immunologicals Biologicals Corp Ltd is roughly -17.7 times. This is much lower than that of the sector, and significantly lower than that of Price to Earning industry, The Price to Earning for all stocks is over 1000% higher than the company.

Peer Comparison

Bharat Immunologicals Price to Earning Comparison
Bharat Immunologicals is currently under evaluation in price to earning category among related companies.

Did you try this?

Run Equity Search Now
   

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
Hide  View All  Next  Launch Equity Search

Fundamental Indicators

Current Bharat Immunologicals financial ratios